Work for Capricor Therapeutics, Inc.?

Claim Your Profile

Capricor Therapeutics, Inc. Logo Image

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. Banner Image

About Capricor Therapeutics, Inc.

11-50 Employees
Based in Los Angeles, California

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases. Capricor’s lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy and COVID-19. Capricor is also investigating the field of extracellular vesicles and exploring the potential of exosome-based candidates to treat or prevent a variety of disorders.

Ticker:
CAPR
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol